Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for intrauterine growth restriction (IUGR) at gestational age above 28 weeks
TCTR20200526006Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sildenafil in intrauterine growth restriction (IUGR), sponsored by Iran University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on TCTR20200526006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200526006.